Exclusive: Warby Parker Seeks to Raise $75 Million
Warby Parker is looking to raise $75 million for its Series E round of financing, Cheddar has learned.
The eyewear company disclosed its plans to raise money in a filing with the state of Delaware on March 7 that was signed by its president Neil Blumenthal and provided to Cheddar by [Lagniappe Labs](https://primeunicornindex.com/).
A spokesperson for Warby Parker didn't respond to a request for comment.
The company last raised $100 million in 2015 for its Series D at a $1.2 billion valuation. It's is seeking a higher share price for its Series E, which indicates that its valuation will likely be higher after it completes the financing round.
Since last raising money, Warby Parker has significantly expanded its retail footprint and plans to have nearly 100 stories open in the U.S. by the end of 2018. Last year it opened a $16 million optical lab dedicated to building its own glasses in-house. And in January, it started selling products for kids for the first time.
Warby Parker has raised $216 million in total since its founding in 2010 from investors such as General Catalyst, T. Rowe Price, and Lerer Hippeau Ventures.
*Reporting by Alex Heath*
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
